Skip to main content
Log in

Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

Moderate hyperhomocysteinaemia has been linked to an increased risk for cardiovascular diseases. Increased homocysteine concentrations may follow folate depletion due to insufficient dietary intake of the vitamin, but there is also some indication that immune activation could play a role. In this preliminary study, homocysteine, folate, and vitamin B12 concentrations were measured in 19 patients with Parkinson's disease, 61–90 years of age, and compared to a healthy control group of similar age and to neopterin concentrations as an indicator of immune activation. A subgroup of patients presented with increased homocysteine and low folate concentrations. Homocysteine levels correlated inversely with vitamins folate and B12 and positively with neopterin concentrations. Disturbed homocysteine metabolism in Parkinson's disease may be associated with vitamin deficiency and with immune system activation which may underlie folate depletion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received January 8, 2002; accepted May 3, 2002 Published online June 28, 2002

Acknowledgement This work was supported by the Austrian Funds “zur Förderung der wissenschaftlichen Forschung”, project 14942.

Authors' address: Dr. D. Fuchs, Institute of Medical Chemistry and Biochemistry, University of Innsbruck, Fritz Pregl Strasse 3, A-6020 Innsbruck, Austria, e-mail: dietmar.fuchs@uibk.ac.at

Rights and permissions

Reprints and permissions

About this article

Cite this article

Widner, B., Leblhuber, F., Frick, B. et al. Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease. J Neural Transm 109, 1445–1452 (2002). https://doi.org/10.1007/s00702-002-0758-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-002-0758-8

Navigation